Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
2 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
In-depth characterization of long-term humoral and cellular immune responses to COVID-19m-RNA vaccination in multiple sclerosis patients treated with teriflunomide or alemtuzumab.
Mult Scler Relat Disord. 2023 Apr;72:104616. doi: 10.1016/j.msard.2023.104616. Epub 2023 Mar 12.
Mult Scler Relat Disord. 2023.
PMID: 36933299
Free PMC article.
Cladribine treatment for highly active multiple sclerosis: Real-world clinical outcomes for years 3 and 4.
Magalashvili D, Mandel M, Dreyer-Alster S, Didikin M, Harari G, Flechter S, Achiron A.
Magalashvili D, et al. Among authors: didikin m.
J Neuroimmunol. 2022 Nov 15;372:577966. doi: 10.1016/j.jneuroim.2022.577966. Epub 2022 Sep 6.
J Neuroimmunol. 2022.
PMID: 36162338
Item in Clipboard
Cite
Cite